Medicine prices, availability, and affordability in the Shaanxi Province in China: implications for the future

International Journal of Clinical Pharmacy

Volumn 37, Issue 1, 2015, Pages 12-17

  Jiang, Minghuan ^a   Zhou, Zhongliang ^a   Wu, Lina ^a   Shen, Qian ^a   Lv, Bing ^a   Wang, Xiao ^a   Yang, Shimin ^a   Fang, Yu ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Affordability; Availability; China; Essential medicine; Pharmacoepidemiology; Prices; WHO HAI methodology

Indexed keywords

ACICLOVIR; ALBENDAZOLE; AMITRIPTYLINE; AMLODIPINE; AMOXICILLIN; ATENOLOL; ATORVASTATIN; AZITHROMYCIN; CAPTOPRIL; CARBAMAZEPINE; CEFALEXIN; CEFRADINE; CEFTAZIDIME; CEFTRIAXONE; CIMETIDINE; CIPROFLOXACIN; COTRIMOXAZOLE; DIAZEPAM; DICLOFENAC; DIGOXIN; ENALAPRIL; ERYTHROMYCIN; FLUCONAZOLE; FLUOXETINE; GENERIC DRUG; GLICLAZIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; ISOSORBIDE MONONITRATE; UNINDEXED DRUG; ESSENTIAL DRUG;

ARTICLE; CHINA; CLINICAL PHARMACY; DRUG AFFORDABILITY; DRUG AVAILABILITY (PHARMACOECONOMICS); DRUG COST; GOVERNMENT WORKER; HEALTH CARE ACCESS; NONMEDICAL OCCUPATIONS; PRIORITY JOURNAL; PRIVATE PHARMACY; PUBLIC HOSPITAL; SALARY; ECONOMICS; EPIDEMIOLOGY; FEE; FORECASTING; HEALTH CARE DELIVERY; HUMAN; PHARMACY; TRENDS;

CHINA; COMMUNITY PHARMACY SERVICES; DRUGS, ESSENTIAL; DRUGS, GENERIC; FEES, PHARMACEUTICAL; FORECASTING; HEALTH SERVICES ACCESSIBILITY; HOSPITALS, PUBLIC; HUMANS;

EID: 84925490315     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-0037-4     Document Type: Article

References (13)

1. Hogerzeil HV. Essential medicines and human rights: what can they learn from each other? Bull World Health Organ. 2006;84(5):371–5.
2. WHO. The world medicines situation 2011-access to essential medicines as part of the right to health. Geneva: World Health Organization; 2011.
3. WHO. WHO medicines strategy countries at the core 2004–2007. Geneva: World Health Organization; 2008.
4. National Health and Family Planning Commission of the People’s Republic of China. China Health Statistical Yearbook 2012. 2013. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2012/index2012.html. Accessed 3 Nov 2013.
5. The Shaanxi Provincial Government. The suggestions for implementing National Essential Medicine System. 2009. http://www.sndrc.gov.cn/view.jsp?ID=16096. Accessed 19 Nov 2011.
6. Jiang MH, Yang SM, Yan KK, Liu J, Zhao J, Fang Y. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi Province of China. PLoS One. 2013;8(8):e70836.
7. World Health Organization, Health Action International. Measuring medicine prices, availability, affordability and price components 2nd ed. 2008. http://www.haiweb.org/medicineprices/manual/documents.html. Accessed 13 Jun 2010.
8. Li H, Guan XD, Xu LP, Liu Y, Han X, Shi LW. Empirical research of price difference and market share between brand-name drugs and generics in one province in China. Chin J New Drugs. 2012;21(24):2853–6.
9. National Development and Reform Commission. The notice of further adjustment of prices of medicines and medical care. http://bgt.ndrc.gov.cn/zcfb/200606/t20060602_499329.html. Accessed 20 Nov 2013.
10. Singal GL. Medicine prices and availability in the state of Harayana, India. http://www.haiweb.org/GlobalDatabase/Main.htm. Accessed 12 Sept 2014.
11. Kotwani A. Medicine prices in the state of Rajasthan, India. http://www.haiweb.org/medicineprices/surveys/200306IN/survey_report.pdf. Accessed 12 Sept 2014.
12. Zeng WJ. A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China. BMC Health Serv Res. 2013;13(10):390–7.
13. Yip WC, Hsiao WC, Chen W, Hu SL, Ma J, et al. Early appraisal of China’s huge and complex health-care reforms. Lancet. 2012;379:833–42.